(MedPage Today) -- CHICAGO -- An investigational bispecific antibody targeting PD-1 and VEGF significantly decreased the risk of disease progression or death in patients with metastatic EGFR-mutant non-small cell lung cancer (NSCLC) who…
While CAR T cell therapy has revolutionized treatment for many blood cancers, including non-Hodgkin lymphoma (NHL), many patients who receive CAR T cell therapy do not experience a long-term remission. For those whose cancers return or…
MANNHEIM, Germany, June 01, 2024 (GLOBE NEWSWIRE) -- Affimed N.V. (NASDAQ:AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, today announced longer follow-up data from…
Clinicians at Georgetown University's Lombardi Comprehensive Cancer Center reported promising preliminary findings based on outcomes in the first six patients with metastatic pancreatic cancer enrolled in a Phase II clinical trial of the…
The United Kingdom (UK) says it is set to begin a “matchmaking” service called the cancer vaccine launch pad (CVLP), which can match patients with suitable trials. In the project, which will be run by the Southampton Clinical Trials Unit …
Explore how personalized cancer vaccines could be a 'game-changer' in cancer treatment. Discover the latest advancements and their potential to transform patient care. Read more!
Pfizer expects its cancer drug Lorbrena to top $1 billion in annual sales by 2030 after most patients treated for a form of lung cancer had no disease progression after five years.
Cancer is the leading cause of disease-related death in children in most developed countries, and at least a quarter of these patients are diagnosed with aggressive high-risk or relapsed cancers, with an expected five-year survival rate of…
Cancer is the leading cause of disease-related death in children in most developed countries, and at least a quarter of these patients are diagnosed with aggressive high-risk or relapsed cancers, with an expected five-year survival rate of…
Data from a large prospective cohort study reveal that a polygenic risk score has the potential to predict survival outcomes in patients with breast cancer.
The United Kingdom's National Health Service (NHS) is fast-tracking patients for its game-changing cancer vaccine trials — and each one will be tailored to every individual's needs. As The Guardian reports, patients who meet eligibility…
Mira Solmaz, 33, used the credit cards of cancer patients she was supposed to take care of during the Covid lockdown and when they were unable to see their family, Southwark Crown Court heard.
Researchers from The University of Texas MD Anderson Cancer Center presented positive clinical results from two studies today at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting.